Marina V Zavyalova
Overview
Explore the profile of Marina V Zavyalova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
230
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patysheva M, Kolegova E, Khozyainova A, Prostakishina E, Korobeynikov V, Menyailo M, et al.
Sci Rep
. 2024 Nov;
14(1):26255.
PMID: 39482351
Tongue cancer at a young age demonstrates an increase in incidence, aggressiveness, and poor response to therapy. Classic etiological factors for head and neck tumors such as tobacco, alcohol, and...
2.
Perelmuter V, Grigoryeva E, Alifanov V, Kalinchuk A, Andryuhova E, Savelieva O, et al.
Int J Mol Sci
. 2024 Oct;
25(20).
PMID: 39456890
Most studies on CTCs have focused on isolating cells that express EpCAM. In this study, we emphasize the presence of EpCAM-negative and EpCAM CTCs, in addition to EpCAM CTCs, in...
3.
Grigoryeva E, Tashireva L, Savelieva O, Zavyalova M, Popova N, Kuznetsov G, et al.
Int J Mol Sci
. 2023 Feb;
24(3).
PMID: 36769251
Integrins are cell adhesion receptors, which play a role in breast cancer invasion, angiogenesis, and metastasis. Moreover, it has been shown that exosomal integrins provide organotropic metastasis in a mouse...
4.
Grigoryeva E, Tashireva L, Alifanov V, Savelieva O, Vtorushin S, Zavyalova M, et al.
Int J Mol Sci
. 2022 Aug;
23(16).
PMID: 36012742
Stemness and epithelial-mesenchymal plasticity are widely studied in the circulating tumor cells of breast cancer patients because the roles of both processes in tumor progression are well established. An important...
5.
Pankova O, Tashireva L, Rodionov E, Miller S, Tuzikov S, Pismenny D, et al.
Front Oncol
. 2021 Dec;
11:771802.
PMID: 34858851
Background: The study assessed the possibility of dividing patients into groups based on the assessment of morphological changes in the epithelium of small-caliber bronchi located near the primary tumor in...
6.
Tashireva L, Savelieva O, Grigoryeva E, Nikitin Y, Denisov E, Vtorushin S, et al.
Int J Mol Sci
. 2021 Apr;
22(5).
PMID: 33801519
To date, there is indisputable evidence of significant CTC heterogeneity in carcinomas, in particular breast cancer. The heterogeneity of CTCs is manifested in the key characteristics of tumor cells related...
7.
Schegoleva A, Khozyainova A, Fedorov A, Gerashchenko T, Rodionov E, Topolnitsky E, et al.
Cell Physiol Biochem
. 2021 Mar;
55(S2):29-48.
PMID: 33687819
Despite advances in diagnostics and therapy of non-small cell lung cancer (NSCLC), the problem of prognosis and prevention of tumor progression is still highly important. Even if NSCLC is diagnosed...
8.
Gerashchenko T, Zolotaryova S, Kiselev A, Tashireva L, Novikov N, Krakhmal N, et al.
Cancers (Basel)
. 2020 Jul;
12(7).
PMID: 32679794
Intratumor morphological heterogeneity reflects patterns of invasive growth and is an indicator of the metastatic potential of breast cancer. In this study, we used this heterogeneity to identify molecules associated...
9.
Savelieva O, Tashireva L, Kaigorodova E, Buzenkova A, Mukhamedzhanov R, Grigoryeva E, et al.
Int J Mol Sci
. 2020 Apr;
21(8).
PMID: 32316333
The presence of stem and epithelial-mesenchymal-transition (EMT) features in circulating tumor cells (CTCs) determines their invasiveness, adaptability to the microenvironment, and resistance to proapoptotic signals and chemotherapy. It also allows...
10.
Tashireva L, Zavyalova M, Savelieva O, Gerashchenko T, Kaigorodova E, Denisov E, et al.
Front Oncol
. 2020 Mar;
10:50.
PMID: 32154161
The identification of tumor cells that can be potential metastatic seeds would reach two key aims-prognosis of metastasis risk and appointment of the optimal adjuvant therapy to prevent metastatic disease....